382 related articles for article (PubMed ID: 29506228)
1. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
Baracos VE; Arribas L
Ann Oncol; 2018 Feb; 29(suppl_2):ii1-ii9. PubMed ID: 29506228
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
Baracos VE; Arribas L
Ann Oncol; 2018 Feb; 29 Suppl 2():ii1-ii9. PubMed ID: 32169202
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
4. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
5. Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity.
Marriott CJC; Beaumont LF; Farncombe TH; Cranston AN; Athale UH; Yakemchuk VN; Webber CE; Barr RD
Cancer; 2018 Mar; 124(6):1225-1231. PubMed ID: 29231963
[TBL] [Abstract][Full Text] [Related]
6. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Sarcopenic Obesity in Cancer.
Carneiro IP; Mazurak VC; Prado CM
Curr Oncol Rep; 2016 Oct; 18(10):62. PubMed ID: 27541923
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
Elliott JA; Doyle SL; Murphy CF; King S; Guinan EM; Beddy P; Ravi N; Reynolds JV
Ann Surg; 2017 Nov; 266(5):822-830. PubMed ID: 28796017
[TBL] [Abstract][Full Text] [Related]
10. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection.
Mueller TC; Henselmann M; Reischl S; Jaeger C; Trefzer C; Demir IE; Friess H; Martignoni ME
BMC Surg; 2024 Jun; 24(1):175. PubMed ID: 38835067
[TBL] [Abstract][Full Text] [Related]
11. Differences in Prevalence of Muscle Wasting in Patients Receiving Peritoneal Dialysis per Dual-Energy X-Ray Absorptiometry Due to Variation in Guideline Definitions of Sarcopenia.
Hung R; Wong B; Goldet G; Davenport A
Nutr Clin Pract; 2017 Aug; 32(4):539-544. PubMed ID: 28760111
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.
Prado CM; Cushen SJ; Orsso CE; Ryan AM
Proc Nutr Soc; 2016 May; 75(2):188-98. PubMed ID: 26743210
[TBL] [Abstract][Full Text] [Related]
13. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
14. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004.
Batsis JA; Mackenzie TA; Lopez-Jimenez F; Bartels SJ
Nutr Res; 2015 Dec; 35(12):1031-9. PubMed ID: 26472145
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenic obesity in cancer.
Jurdana M; Cemazar M
Radiol Oncol; 2024 Mar; 58(1):1-8. PubMed ID: 38378031
[TBL] [Abstract][Full Text] [Related]
17. [The prevalence of sarcopenic obesity in postmenopausal women in depending on the used methodology - preliminary study].
Milewska M; Sińska B; Sych D; Kucharska A
Pol Merkur Lekarski; 2015 Apr; 38(226):206-10. PubMed ID: 25938387
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.
Meng P; Hu YX; Fan L; Zhang Y; Zhang MX; Sun J; Liu Y; Li M; Yang Y; Wang LH; Zhang Y; Gao W; Han XQ; Chen LK
Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():29-35. PubMed ID: 24450558
[TBL] [Abstract][Full Text] [Related]
19. SARCOPENIA, OBESITY AND SARCOPENIC OBESITY IN LIVER TRANSPLANTATION: A BODY COMPOSITION PROSPECTIVE STUDY.
Anastácio LR; Ferreira LG; Ribeiro HS; Diniz KGD; Lima AS; Correia MITD; Vilela EG
Arq Bras Cir Dig; 2019; 32(2):e1434. PubMed ID: 31038559
[TBL] [Abstract][Full Text] [Related]
20. Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer.
Jochum SB; Kistner M; Wood EH; Hoscheit M; Nowak L; Poirier J; Eberhardt JM; Saclarides TJ; Hayden DM
Colorectal Dis; 2019 Dec; 21(12):1372-1378. PubMed ID: 31276286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
